share_log

BioVie | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Terren S. Peizer(44.53%),Acuitas Group Holdings, LLC(44.47%)

BioVie | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Terren S. Peizer(44.53%),Acuitas Group Holdings, LLC(44.47%)

BioVie | SC 13D/A:超過5%持股股東披露文件(修正)-Terren S. Peizer(44.53%),Acuitas Group Holdings, LLC(44.47%)
美股SEC公告 ·  2024/06/26 07:50

Moomoo AI 已提取核心訊息

On June 21, 2024, Terren S. Peizer, associated with Acuitas Group Holdings, LLC, was found guilty of securities fraud and insider trading related to the sale of shares of Ontrak, Inc. The conviction is subject to appeal. This information was disclosed in an amendment to Schedule 13D filed with the SEC, which also reported that Acuitas and Mr. Peizer collectively hold a significant stake in BioVie Inc. As of June 25, 2024, Acuitas may be deemed to have beneficial ownership of 30,435,738 shares of BioVie's Common Stock, representing approximately 44.47% of the company. Mr. Peizer may be deemed to have beneficial ownership of 30,503,938 shares, representing about 44.53% of the outstanding Common Stock. These figures include shares that may be issued upon the exercise of a warrant and options that became fully vested and exercisable as of March 2, 2023. The filing confirms that there have been no transactions in the company's securities by the reporting persons in the past sixty days.
On June 21, 2024, Terren S. Peizer, associated with Acuitas Group Holdings, LLC, was found guilty of securities fraud and insider trading related to the sale of shares of Ontrak, Inc. The conviction is subject to appeal. This information was disclosed in an amendment to Schedule 13D filed with the SEC, which also reported that Acuitas and Mr. Peizer collectively hold a significant stake in BioVie Inc. As of June 25, 2024, Acuitas may be deemed to have beneficial ownership of 30,435,738 shares of BioVie's Common Stock, representing approximately 44.47% of the company. Mr. Peizer may be deemed to have beneficial ownership of 30,503,938 shares, representing about 44.53% of the outstanding Common Stock. These figures include shares that may be issued upon the exercise of a warrant and options that became fully vested and exercisable as of March 2, 2023. The filing confirms that there have been no transactions in the company's securities by the reporting persons in the past sixty days.
2024年6月21日,與Acuitas Group Holdings, LLC相關聯的Terren S. Peizer因涉嫌證券欺詐和內幕交易而被判有罪,涉及Ontrak,Inc股票的銷售。這一定罪判決可以上訴。這是在提交給美國證券交易委員會的13D表格修訂中披露的信息,該表格還報告Acuitas和Peizer先生共持有BioVie Inc的大部分股權。截至2024年6月25日,Acuitas可能被視爲持有BioVie普通股的30,435,738股,佔公司股份的約44.47%。Peizer先生可能被視爲持有30,503,938股,約佔流通普通股的44.53%。這些數據包括可以行使權證和期權的股份,截至2023年3月2日已經全面授予並行使。該報告證實在過去60天內報告人並沒有進行該公司證券的任何交易。
2024年6月21日,與Acuitas Group Holdings, LLC相關聯的Terren S. Peizer因涉嫌證券欺詐和內幕交易而被判有罪,涉及Ontrak,Inc股票的銷售。這一定罪判決可以上訴。這是在提交給美國證券交易委員會的13D表格修訂中披露的信息,該表格還報告Acuitas和Peizer先生共持有BioVie Inc的大部分股權。截至2024年6月25日,Acuitas可能被視爲持有BioVie普通股的30,435,738股,佔公司股份的約44.47%。Peizer先生可能被視爲持有30,503,938股,約佔流通普通股的44.53%。這些數據包括可以行使權證和期權的股份,截至2023年3月2日已經全面授予並行使。該報告證實在過去60天內報告人並沒有進行該公司證券的任何交易。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息